| Followers | 128 |
| Posts | 2150 |
| Boards Moderated | 1 |
| Alias Born | 12/27/2007 |
Friday, May 02, 2014 7:12:42 AM
Adherex has enough Cash until year end /early 2015 . They have $1.7 M Cash and a very low Burn-rate of $400k per Quarter .There also warrants at $1.44 which could bring more cash for another 2+ years if they exercise them .
And if Phase 3 is positive then you can be sure that they can raise money at much much higher level without problems .
And if Phase 3 is positive then you can be sure that they can raise money at much much higher level without problems .
Recent FENC News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 02:58:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:24:42 PM
- Fennec Pharmaceuticals Shares Rise After Earnings and Revenue Beat Forecasts (FENC) • IH Market News • 05/14/2026 12:47:47 PM
- Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2026 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 09:00:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2026 08:15:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:05:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:46:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:09:04 PM
- Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/21/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:27:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 08:38:18 PM
- Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/31/2026 10:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2026 08:44:02 PM
